tetano
Editor, Senior Moderator
J Clin Med
. 2021 Nov 22;10(22):5444.
doi: 10.3390/jcm10225444.
Feasibility and Clinical Outcomes of a Step Up Noninvasive Respiratory Support Strategy in Patients with Severe COVID-19 Pneumonia
Silvia Coppola[SUP] 1 [/SUP], Pierachille Santus[SUP] 2 3 [/SUP], Giovanni Sotgiu[SUP] 4 [/SUP], Michele Mondoni[SUP] 5 [/SUP], Alessia Gandola[SUP] 1 [/SUP], Marina Saad[SUP] 2 3 [/SUP], Giuseppe Francesco Sferrazza Papa[SUP] 6 7 [/SUP], Stefano Centanni[SUP] 5 6 [/SUP], Laura Saderi[SUP] 4 [/SUP], Davide Alberto Chiumello[SUP] 1 6 8 [/SUP], Dejan Radovanovic[SUP] 3 [/SUP]
Affiliations
Abstract
The best noninvasive respiratory strategy in patients with Coronavirus Disease 2019 (COVID-19) pneumonia is still discussed. We aimed at assessing the rate of endotracheal intubation (ETI) in patients treated with continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) if CPAP failed. Secondary outcomes were in-hospital mortality and in-hospital length of stay (LOS). A retrospective, observational, multicenter study was conducted in intermediate-high dependency respiratory units of two Italian university hospitals. Consecutive patients with COVID-19 treated with CPAP were enrolled. Thoraco-abdominal asynchrony or hemodynamic instability led to ETI. Patients showing SpO[SUB]2[/SUB] ≤ 94%, respiratory rate ≥ 30 bpm or accessory muscle activation on CPAP received NIV. Respiratory distress and desaturation despite NIV eventually led to ETI. 156 patients were included. The overall rate of ETI was 30%, mortality 18% and median LOS 24 (17-32) days. Among patients that failed CPAP (n = 63), 28% were intubated, while the remaining 72% received NIV, of which 65% were intubated. Patients intubated after CPAP showed lower baseline PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB], lower lymphocyte counts and higher D-dimer values compared with patients intubated after CPAP + NIV. Mortality was 22% with CPAP + ETI, and 20% with CPAP + NIV + ETI. In the case of CPAP failure, a NIV trial appears feasible, does not deteriorate respiratory status and may reduce the need for ETI in COVID-19 patients.
Keywords: COVID-19; acute respiratory failure; continuous positive airway pressure; intubation; mortality; noninvasive ventilation.
. 2021 Nov 22;10(22):5444.
doi: 10.3390/jcm10225444.
Feasibility and Clinical Outcomes of a Step Up Noninvasive Respiratory Support Strategy in Patients with Severe COVID-19 Pneumonia
Silvia Coppola[SUP] 1 [/SUP], Pierachille Santus[SUP] 2 3 [/SUP], Giovanni Sotgiu[SUP] 4 [/SUP], Michele Mondoni[SUP] 5 [/SUP], Alessia Gandola[SUP] 1 [/SUP], Marina Saad[SUP] 2 3 [/SUP], Giuseppe Francesco Sferrazza Papa[SUP] 6 7 [/SUP], Stefano Centanni[SUP] 5 6 [/SUP], Laura Saderi[SUP] 4 [/SUP], Davide Alberto Chiumello[SUP] 1 6 8 [/SUP], Dejan Radovanovic[SUP] 3 [/SUP]
Affiliations
- PMID: 34830728
- DOI: 10.3390/jcm10225444
Abstract
The best noninvasive respiratory strategy in patients with Coronavirus Disease 2019 (COVID-19) pneumonia is still discussed. We aimed at assessing the rate of endotracheal intubation (ETI) in patients treated with continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) if CPAP failed. Secondary outcomes were in-hospital mortality and in-hospital length of stay (LOS). A retrospective, observational, multicenter study was conducted in intermediate-high dependency respiratory units of two Italian university hospitals. Consecutive patients with COVID-19 treated with CPAP were enrolled. Thoraco-abdominal asynchrony or hemodynamic instability led to ETI. Patients showing SpO[SUB]2[/SUB] ≤ 94%, respiratory rate ≥ 30 bpm or accessory muscle activation on CPAP received NIV. Respiratory distress and desaturation despite NIV eventually led to ETI. 156 patients were included. The overall rate of ETI was 30%, mortality 18% and median LOS 24 (17-32) days. Among patients that failed CPAP (n = 63), 28% were intubated, while the remaining 72% received NIV, of which 65% were intubated. Patients intubated after CPAP showed lower baseline PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB], lower lymphocyte counts and higher D-dimer values compared with patients intubated after CPAP + NIV. Mortality was 22% with CPAP + ETI, and 20% with CPAP + NIV + ETI. In the case of CPAP failure, a NIV trial appears feasible, does not deteriorate respiratory status and may reduce the need for ETI in COVID-19 patients.
Keywords: COVID-19; acute respiratory failure; continuous positive airway pressure; intubation; mortality; noninvasive ventilation.